To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06828991
Title A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients with Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of CtDNA (circulating Tumor DNA) At the End of Treatment with Pola-R-mini-CHP (GOLD)
Acronym GOLD
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Danielle Wallace
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
Wilmot Cancer Institute Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field